Discussion Overview
The discussion revolves around the presence of evidence for Crohn's Disease during periods of remission, particularly in relation to colonoscopy findings. Participants explore the implications of immunological markers and clinical definitions of remission, as well as the challenges in diagnosing the disease when symptoms are absent.
Discussion Character
- Exploratory
- Technical explanation
- Debate/contested
Main Points Raised
- Some participants question whether evidence of Crohn's Disease can be present during remission, noting that colonoscopies may provide clues that are not exclusive to flare-ups.
- One participant mentions increased activity of immunocompetent cells and TNF-\alpha levels in the intestinal mucosa during some remissions, but expresses uncertainty about the specificity of these markers for Crohn's Disease without prior diagnosis.
- There is mention of personal and family history as potential evidence for prior activation of undiagnosed Crohn's Disease, alongside physical signs such as fistulas and intestinal wall thickening.
- Another participant defines clinical remission as a lack of symptoms, which translates to mucosal healing, and references additional reading material.
- A later contribution discusses the challenges of identifying early clinical relapse in Crohn's Disease during remission, highlighting that no sub-clinical markers currently predict relapse.
- It is noted that persistent local immune activation may serve as a marker for early clinical relapse, with references to ongoing studies investigating this relationship.
Areas of Agreement / Disagreement
Participants express differing views on the presence of evidence for Crohn's Disease during remission, with some suggesting that immunological markers may persist while others emphasize the lack of definitive diagnostic criteria. The discussion remains unresolved regarding the implications of these findings.
Contextual Notes
Limitations include the absence of consensus on the specificity of immunological markers for Crohn's Disease during remission and the challenges in diagnosing the disease without clear symptoms or established criteria.